Division of Hematology/Oncology

Faculty

faculty photo

Nevena Damjanov, MD

Associate Professor of Clinical Medicine
Attending Physician, Hospital of the University of Pennsylvania
Attending Physician, Penn Presbyterian Medical Center
Director of GI Oncology, Abramson Cancer Center at the Penn Presbyterian Medical Center
Director, Clinical Research Program, Abramson Cancer Center at the Penn Presbyterian Medical Center
Department: Medicine

Contact information
Penn Presbyterian Medical Center
51 North 39th Street
103A MAB
Philadelphia, PA 19104
Office: 215-662-9801
Fax: 215-243-3249
Education:
BA (Biology, Philosophy)
University of Pennsylvania, 1985.
MD (Internal Medicine)
Hahnemann University, 1989.
CTF (Leading Success)
Raymond and Ruth Perelman School of Medicine University of Pennsylvania, 2015.
Post-Graduate Training
Residency in Internal Medicine, M.S. Hershey Medical Center, 1989-1992.
Fellowship in Hematology/Oncology, University of Pennsylvania Medical Center, 1992-1996.
Certifications
American Board of Internal Medicine (Internal Medicine), 1992.
American Board of Internal Medicine (Medical Oncology), 1995.
American Board of Internal Medicine (Hematology), 1996.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Lea Lowenfeld MD, Jashodeep Datta MD, Russell S. Lewis Jr., Matthew T. McMillan, Ronac Mamtani MD, Nevena Damjanov MD, Vinay Chandrasakhara MD, Giorgos Karakousis MD, Jeffrey Drebin MD PhD, Douglas Fraker MD, Robert E. Roses MD: Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival. Annals of Surgical Oncology 22: 86-72, December 2015.

Vassallo,R; Prechtel-Dunphy,E; Damjanov,N; Tsikouras,A; Favatella,J; Kasbekar,N.: Impact of Comprehensive Pharmacy Services on Patient Centered Outcomes in an Oncology Clinic. UHC Pharmacy Council Meeting: New Orleans, LA December 2015 Notes: "Poster Presentation"

E.M. Egert, R.D. Johnson, M.M. Watts, J. Booty, N. Damjanov, R. Mohr, M. Lee, N.S. Mungiole, D.E. Kaplan, J. Griffiths, H.A. Shaikh, R.C. Hawley, M.S. Ghosh: A Regional Multidisciplinary Liver Tumor Board improves Access to Hepatocellular Carcinoma Treatment for Patients Geographically Distant from Tertiary Medical Center. AASLD, The Liver Meeting 2015(521), November 2015 Notes: "Poster Presentation"

Mark H. O'Hara, Maryann Gallagher, Ursina R. Teitelbaum, Bruce J. Giantonio, Nevena Damjanov, Arturo Loaiza-Bonilla, Ravi K. Amaravadi, Daniel F Heitjan, Irina Vasilevskaya, Daniel D. Von Hoff, Ramesh K Ramanathan, Dan Laheru, Ana De Jesus-Acosta, Victor E Velculescu, Peter J. O'Dwyer; : Phase 1 trial of gemcitabine/nab-paclitaxel in combination with the autophagy inhibitor hydroxychloroquine in previously untreated patients with metastatic pancreatic adenocarcinoma. J Clin Oncol 33, June 2015 Notes: "Oral Presentation"

Arturo Loaiza-Bonilla, Mark H. O'Hara, Maryann Redlinger, Nevena Damjanov, Ursina R. Teitelbaum, Irina Vasilevskaya, Mark Alan Rosen, Daniel F Heitjan, Ravi K. Amaravadi, Peter J. O'Dwyer;: Phase II trial of autophagy inhibition using hydroxychloroquine (HCQ) with FOLFOX/bevacizumab in the first-line treatment of advanced colorectal cancer. J Clin Oncol 33, June 2015 Notes: "Oral Presentation"

Mark H. O'Hara, Christine Edmonds, Michael Farwell, Rodolfo F. Perini, Daniel A. Pryma, Ursina R. Teitelbaum, Bruce J. Giantonio, Nevena Damjanov, Priti Lal, Michael D Feldman, Paul J. Zhang, David A. Mankoff, Maryann Gallagher, Angela DeMichele, David J. Vaughn, Peter J. O'Dwyer: Phase II pharmacodynamic trial of palbociclib in patients with KRAS mutant colorectal cancer. J Clin Oncol 33(suppl 3; abstr 626), January 2015 Notes: "Oral Presentation"

Divya Yerramilli, Davendra Sohal, Ursina R. Teitelbaum, Paul Stephen Wissel, Nevena Damjanov, Bruce J. Giantonio, Peter J. O'Dwyer, John Peter Plastaras, Edgar Ben-Josef, James M. Metz, John Kucharczuk, Noel Williams, Smith Apisarnthanarax: Adjuvant chemotherapy after trimodality therapy in locally advanced esophageal cancer. J Clin Oncol 32, January 2014 Notes: "Poster Presentation"

Sohal DP, Mykulowycz K, Uehara T, Teitelbaum UR, Damjanov N, Giantonio BJ, Carberry M, Wissel P, Jacobs-Small M, O'Dwyer PJ, Sepulveda A, Sun W.: A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma. Ann Oncol 24(12): 3061-5, December 2013.

Sun, W., Sohal, D., Mykulowycz, K., Teitelbaum, U.R., Damjanov, N., Giantonio, B.J., Carberry, M., Wissel, P., Jacobs-Small, M., O’Dwyer, P.J.: An interim evaluation of efficacy and safety of the combination of panitumumab, gemcitabine, and irinotecan in patients with advanced or metastatic cholangiocarcinoma: A phase II study. Journal of Clinical Oncology 30(328a), June 2012 Notes: Poster presentation and abstract.

Davendra Sohal, Ursina R. Teitelbaum, Takeshi Uehara, Kristine Mykulowycz, Christopher D. Watt, Nevena Damjanov, Bruce J. Giantonio, Mary Carberry, Paul Stephen Wissel, Mona Jacobs-Small, Peter J. O'Dwyer, Antonia Sepulveda, Weijing Sun;: A phase II trial of gemcitabine, irinotecan, and panitumumab in advanced cholangiocarcinoma, with correlative analysis of EGFR, KRAS, and BRAF: An interim report. J Clin Oncol 30, June 2012 Notes: "Poster Presentation"

back to top
Last updated: 02/12/2016
The Trustees of the University of Pennsylvania
 

Clinical Briefings Blog Spot

Penn MD Forum title with Penn Medicine Shield and Twitter